학술논문

Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 study
Document Type
Article
Source
In: Investigational New Drugs. (Investigational New Drugs, October 2022, 40(5):1051-1065)
Subject
Language
English
ISSN
15730646
01676997